BioGaia signs agreement with Moroccan pharmaceutical company Galenica SA for Morocco
(Thomson Reuters ONE) -
BioGaia signs agreement with Moroccan pharmaceutical company Galenica SA for
Morocco
The agreement with Galenica gives the company exclusive rights to distribute
BioGaia's Probiotic drops and tablets under the BioGaia brand in Morocco. The
launch is planned for the first quarter of 2012.
Galenica, Morocco's third largest pharmaceutical company in terms of units sold,
was founded in 1987 by Abdelghani El Guermai and remains under his family's
ownership today. Galenica has 400 employees, of whom 120 are sales
representatives.
The Moroccan economy is growing fast. With a population of 32 million people and
630,000 newborn babies per year, it is an attractive market for BioGaia.
"We are pleased that the agreement has given us access to an interesting new
region with strong growth and that our products are launched in yet another
country," says Peter Rothschild, President of BioGaia.
BioGaia's finished products, such as Probiotic drops and tablets, are now sold
in 52 countries. In 34 countries, the products are sold under the BioGaia brand.
Latest press releases from BioGaia:
2011-05-11 Annual General Meeting of BioGaia
2011-05-10 BioGaia AB Interim report 1 January - 31 March 2011
2011-04-04 Notice to attend the Annual General Meeting of BioGaia
AB (publ)
For additional information:
Peter Rothschild, President, telephone: +46 8-555 293 00
BioGaia has published this information in accordance with the Swedish Securities
Markets Act. The information was submitted for publication on 4 August
2011, 10:00 a.m.
BioGaia is a biotechnology company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic,
health-enhancing effects. The class B share of the Parent Company BioGaia AB is
quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm.
www.biogaia.com
Press release August 4, 2011:
http://hugin.info/86913/R/1536163/468655.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioGaia AB via Thomson Reuters ONE
[HUG#1536163]
Unternehmensinformation / Kurzprofil:
Datum: 04.08.2011 - 10:00 Uhr
Sprache: Deutsch
News-ID 56983
Anzahl Zeichen: 3020
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 211 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioGaia signs agreement with Moroccan pharmaceutical company Galenica SA for Morocco"
steht unter der journalistisch-redaktionellen Verantwortung von
BioGaia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
